Track: Cardiomyopathies and Heart Failure

Cardiomyopathies are a group of disorders that affect the heart muscle and decrease its capacity to pump blood efficiently. They can cause heart enlargement, thickness, or stiffness, which reduces cardiac function. The three most common forms are dilated, hypertrophic, and restrictive cardiomyopathies, each with its own set of characteristics and causes. Cardiomyopathies can be inherited or acquired, and symptoms may include shortness of breath, tiredness, and arrhythmias. If not addressed, these disorders can lead to heart failure and other significant problems. These disorders can cause cardiac failure and other severe problems.
Sub topics under cardiomyopathies includes:
- Dilated Cardiomyopathies
- Takotsubo Cardiomyopathy
- Hypertrophic Cardiomyopathy
- Cardiac Amyloidosis
- Restrictive Cardiomyopathy
- Arrhythmogenic Right Ventricular Dysplasia
- Myocardial Infarction
- Alcoholic and Congestive Cardiomyopathy
- Diabetic and Peripartum Cardiomyopathy
- Familial Dilated Cardiomyopathy
- Idiopathic and Ischemic Cardiomyopathy
- Asymmetric Septal Hypertrophy
- Familial Hypertrophic Cardiomyopathy
- Genetic Basis of Cardiomyopathies
- Role of Cardiac MRI in Diagnosis
- Advances in Treatment Options
- Role of ICDs and Pacemakers
- Heart Failure Management in Cardiomyopathy
- Cardiomyopathy in Pediatric Patients
- Role of Exercise and Rehabilitation
- Impact of Lifestyle Modifications
- Innovations in Gene Therapy
- Cardiomyopathy and Pregnancy
- Long-Term Outcomes and Follow-Up
Cardiomyopathies are often managed with drugs, lifestyle adjustments, and, in some cases, surgical treatments or heart transplants. Early identification and treatment are critical for achieving better outcomes and managing symptoms.
Heart failure, which is the final stage of many cardiac disorders, is a complex clinical illness defined by the heart's inability to pump enough blood to meet the body's needs. It is the largest cause of morbidity, mortality, and healthcare burden worldwide. Advances in imaging, genetics, pharmacology, and device therapy are altering patient management, but many unmet problems persist, necessitating continuing study and innovation in this crucial area.
We cordially encourage you to take part in our cardiology conference under the session of "Cardiomyopathies". This is an exceptional opportunity to network with renowned professionals, share your valuable views, and participate in conversations about the most recent breakthroughs in these critical fields. Your input will influence the future of cardiac care and innovation. Register now to take part in this interesting and valuable conference.
Scientific Highlights
- Cardiovascular Diseases
- Cardio Oncology
- Pediatric Cardiology & Congenital Heart Diseases
- Thoracic and Cardiovascular Surgery
- Hypertension and Cardiac Regeneration
- Interventional Cardiology and Cardiac Imaging
- Women and Fetal Cardiology
- Diabetes, Obesity and Stroke
- Vascular Surgery and Vascular Biology
- Molecular and Geriatric Cardiology
- Cardiac Nursing and Critical Care Cardiology
- Arrhythmias and Electrophysiology
- Cardiovascular Pharmacology and Toxicology
- Cardiac Immunology and Bleeding Disorders
- Heart Devices
- Heart Diagnosis and Transplantation
- Cardiovascular Impact of COVID 19
- Preventive Cardiology and Lipidology
- Cardiomyopathies and Heart Failure
- Current Research in Heart & Cardiovascular Disease
- Cardiovascular Anaesthesiology and Endocrinology
- Case Reports on Clinical Cardiology
- Internal and Emergency Medicine